Cadrenal Therapeutics, Inc. (CVKD) vs HCW Biologics Inc. (HCWB)
Cadrenal Therapeutics, Inc. and HCW Biologics Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and HCW Biologics Inc. are of similar size ($4.3M and $4.2M). Cadrenal Therapeutics, Inc. has the higher net margin (0.00% vs −329.4%) and the lower return on invested capital (−427.5% vs −36.2%). Across the 14 metrics below, Cadrenal Therapeutics, Inc. leads on 8 and HCW Biologics Inc. on 6.
Valuation
Profitability
| Metric | CVKD | HCWB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.91% | 65.16% |
| Operating margin | 0.00% | (114.02%) | 0.00% |
| Net margin | 0.00% | (329.38%) | 0.00% |
| Free cash flow margin | 0.00% | (180.57%) | 0.00% |
| Return on equity | (275.16%) | (600.32%) | (57.72%) |
| Return on assets | (199.59%) | (79.52%) | (49.22%) |
| Return on invested capital | (427.54%) | (36.15%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack